Introduction
Osteoarthritis is a worldwide joint disease that affects about 10% of men and 18% of women aged over 60 years (Woolf and Pfleger 2003) . Osteoarthritis is characterized by low bone mass, tissue degeneration, and cartilage loss. It causes pain, joint stiffness, function loss, disability, and leads to severe economic and social burden (Katz 2006; Das and Farooqi 2008; Glynjones et al. 2015) . Osteoarthritis affects joints at different sites, including vertebral column, shoulder, hip, knee, ankle, and temporomandibular joint (Vieira et al. 2015) . Lumbar osteoarthritis, an osteoarthritis disease caused by lumbar degeneration, is very common in China (Tian et al. 2014) . Lumbar osteoarthritis can mainly be classified to facet joint osteoarthritis, facet syndrome, facet joint disease, hypertrophic facet joint arthritis, and degenerative facet joint disease.
Facet joint osteoarthritis is a universal form of lumbar osteoarthritis that can be caused by genetic factors and many environmental factors, such as age, occupation, injury, physical activity, and physical loading (Battie et al. 2002; Riihimäki and Viikari-Juntura 2008) . The features, symptoms, and diagnostic images of facet joint osteoarthritis have been investigated (Gellhorn et al. 2013) . Recently, biomarkers of facet joint osteoarthritis have also been discovered (Nakamura et al. 2016) . Although much knowledge about facet cartilage degeneration has been gained, the pathological changes of facet cartilage degeneration, especially the cellular and molecular changes, remain largely undetermined. Thus, it is urgent to obtain a global view of facet joint osteoarthritis from the cellular and molecular aspect. RNA deep sequencing (RNA-seq) is a widely used high-throughput genotyping method that measures the expression levels of thousands of coding and non-coding genes with high signal-to-noise ratio, high dynamic range, high reliability, and accuracy (Mortazavi et al. 2008; Nagalakshmi et al. 2010; Chen et al. 2017) . Considering that there remains great unknown about facet joint osteoarthritis, in the current study, we collected samples from healthy controls and patients with facet cartilage degeneration and performed RNA-seq. We made comparisons between the expression levels of genes in the control group and the facet joint osteoarthritis group, identified significantly differentially expressed genes, and investigated enriched signaling pathways of these differentially expressed genes by using Kyoto Enrichment of Genes and Genomes (KEGG). Two enriched signaling pathways that were highly related with inflammation, Wnt signaling pathway and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway, were studied in detail.
Materials and Methods

Patient information
Facet joint tissues were collected from 58 donors. In the control group, the medial aspects of facet joints were obtained from spinal level T12 (12 th Thoracic Vertebra) to L2 (2 nd Lumbar Vertebra) of vertebral fracture patients underwent internal fixation of the lumbar spine. In the facet joint osteoarthritis group, the medial aspect of facet joints was obtained from spinal level L3 (3 rd Lumbar Vertebra) to S1 (1 st sacrum Vertebra) of facet joint osteoarthritis patients underwent lumbar surgery for neurogenic claudication due to lumbar spinal canal stenosis caused by facet joint osteoarthritis. Patients with infection, inflammatory diseases or autoimmune diseases were excluded. Magnetic Resonance Imaging (MRI) was performed to identify the degree of cartilage degeneration. Facet joint tissues in the control group were of Grade 0 (normal; n = 7) and Grade 1 (mild degeneration; n = 3). Tissues in the facet joint osteoarthritis group were of Grade 2 (moderate degeneration; n = 20) and Grade 3 (severe degeneration; n = 28). The specific information of patients is summarized in Table 1 . All tissue donors included in this study provided informed consent. The study was approved by the Human Ethics Committee of The Second Affiliated Hospital of Nantong University.
Tissue collection, RNA extraction and RNA-seq
Fresh human facet joint cartilage was immediately separated from the subchondral bone by using a sterile surgical blade. Collected tissues were immediately frozen in liquid nitrogen. A larger amount of facet joint cartilage tissue could be collected from control patients, whereas a smaller amount of facet joint cartilage tissue could be collected from patients with facet joint osteoarthritis due to cartilage degeneration. For facet joint cartilage tissues collected in both groups, we divided tissues into 3 parts for subsequent sequencing analysis. Facet joint tissues in each part were mixed and used as biological and technical triplicates. Specifically, for repetition 1 in the control group, we collected facet joint tissues from three patients with Grade 0 and one patient with Grade 1 cartilage degeneration and made these tissues as a mixed sample. For repetitions 2 and 3 in the control group, we collected facet joint tissues from two patients with Grade 0 and one patient with Grade 1 cartilage degeneration. For repetition 1 in the facet joint osteoarthritis group, we collected facet joint tissues from six patients with Grade 2 and 10 patients with Grade 3 cartilage degeneration and made these tissues as a mixed sample. For repetitions 2 and 3 in the facet joint osteoarthritis group, we collected facet joint tissues from seven patients with Grade 2 and nine patients with Grade 3 cartilage degeneration. The samples were homogenized by using the Cell crusher tissue pulverizer. Total RNA was isolated by using TRIzol reagent (Invitrogen, Carlsbad, CA) and purified by using RNeasy Mini kit (Qiagen, Valencia, CA). High quality RNA samples were achieved. For RNA in the control group, the OD260/280 was 1.76, RNA concentration was 62.51 ng/μl, and RNA Integrity Number (RIN) was 6.2. For RNA in the facet joint osteoarthritis group, the OD260/280 was 1.80, RNA concentration was 34.50 ng/μl, and RIN was 6.2. RNA-seq was performed by using Illumina Hiseq X10 platform. Obtained primary sequencing data were subjected to quality control by using perl scripts. Clean reads were obtained by removing reads with adapters, reads that contains more than 5% unknown bases, and low quality reads. Reference genome and gene model annotation files were directly downloaded from the genome website. The reference genome index was built by using Bowtie (v2.1.0) (Langmead and Salzberg 2012) and paired-end clean reads were aligned to the reference genome using TopHat (v2.1.1) (Kim et al. 2013) .
Bioinformatic analysis
Gene expression levels were calculated by fragments per kilobase of exon per million fragments mapped (FPKM). The expression level of each gene in the facet joint osteoarthritis group was compared with the level in the control group. Gene that obtains a log 2 Ratio ≤ -1 or ≥ 1 and a q-value ≤ 0.05 was assigned as significantly differentially expressed. Differentially expressed genes underwent KEGG analysis to classify correlating gene sets into their respective pathways.
Primer names
Primer
The primers used in this study are listed. qRT-PCR Total RNA was isolated from cartilage tissues by using TRIzol reagent. Isolated RNA was reverse-transcribed and qPCR was performed with an AB Step One Plus Real-Time PCR system. The qPCR conditions were as follows: 95°C for 2 minutes, 40 cycles of 95°C for 15 seconds and 60°C for 30 seconds. The primers used in this study are listed in Table 2 .
Statistical analysis
All data were expressed as mean ± standard error. Student's t-test was used to compare differences between the control groups and the facet joint osteoarthritis group. All statistical analyses were performed with SPSS for Windows 11.0.1 (SPSS Inc., Chicago, IL) and all significance levels were set at p-value < 0.05.
Results
Overview of the transcriptome changes in facet joint osteoarthritis
Three replicated samples from the healthy control group or facet joint osteoarthritis group were collected and underwent RNA isolation and subsequent RNA-seq. The four nitrogen-containing nucleobases (adenine [A], thymine [T], guanine [G] , and cytosine [C]) were randomly distributed, and RNA-seq reads were mapped to the reference genome. These parameters indicated that we achieved high quality outcomes.
The expression levels of genes in the control group and facet joint osteoarthritis group were then determined. A total number of 19,229, 19,039, and 19,311 genes were identified in three replicates in the control group, while a total number of 19,571, 19,431, and 19,554 genes were identified in three replicates in the facet joint osteoarthritis group. A total number of 1,821 differentially expressed genes (log 2 Ratio ≤ -1 or ≥ 1 and q-value ≤ 0.05) were screened. Among these differentially expressed genes, 560 genes were categorized as "up-regulated" and 1,261 genes were categorized as "down-regulated." A volcano plot was drawn for a quick identification of these differentially expressed genes (Fig. 1) . Up-regulated genes are labeled in red and down-regulated genes are labeled in green.
Significantly enriched signaling pathways in facet joint osteoarthritis
After the identification of significantly differentially expressed genes, KEGG analysis was performed to find possible signaling pathways involved in facet joint osteoarthritis. The p-values of these involved signaling pathways were calculated, and a total number of 42 signaling pathways have a p-value < 0.05. According to the significance of signaling pathways, top 30 enriched signaling pathways in facet joint osteoarthritis were screened (Fig. 2) . The number of differentially expressed genes in each signaling pathway and the RichFactor of each signaling pathway are also listed.
According to their biological functions, these significantly enriched signaling pathways could mainly be classified into four groups: disease-related signaling pathways (systemic lupus erythematosus, alchohlism, malaria, transcriptional misregulation in cancer, amoebiasis, p53 signaling pathway, bladder cancer, leishmaniasis, rheumatoid arthritis, and human T-cell lymphotropic virus type 1 (HTLV-I) infection), development-related signaling pathways (hematopoietic cell lineage and osteoclast differentiation), immune and inflammation-related signaling pathways (B cell receptor signaling pathway, primary immunodeficiency, Fc gamma R-mediated phagocytosis, natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Wnt signaling pathway, NF-κB signaling pathway, leukocyte transendothelial migration, Fc epsilon RI signaling pathway, NOD-like receptor signaling pathway, and phagosome), and cell growth and survival-related signaling pathways (extracellular matrix (ECM)-receptor interaction, cytokine-cytokine receptor interaction, chemokines signaling pathway, cell cycle, protein digestion and absorption, cell adhesion molecules, and focal adhesion).
Enriched Wnt signaling pathway and NF-κB signaling pathway in facet joint osteoarthritis
It is not surprising that many immune and inflammation-related signaling pathways were activated in facet joint osteoarthritis as osteoarthritis was generally considered to be highly associated with immune and inflammation. Two immune and inflammation-related signaling pathways, Wnt signaling pathway and NF-κB signaling pathway, have previously been identified to be involved in osteoarthritis (Kobayashi et al. 2013; Rigoglou and Papavassiliou 2013; Takamatsu et al. 2014; Funck-Brentano et al. 2015) . However, whether these two signaling pathways are also activated in facet joint osteoarthritis has not been determined yet. Here, Wnt signaling pathway and NF-κB signaling pathway were investigated in detail to identify their involvement in facet joint osteoarthritis. Based on the KEGG Orthology online database (http:// www.genome.jp/kegg/ko.html), a schematic diagram of Wnt signaling pathway was drawn and differentially expressed genes were labeled with red or green color (Fig.  3A) . In canonical Wnt signaling pathway, gene expression of Dickkopf WNT Signaling Pathway Inhibitor 2 (DKK2), Sex-determining Region Y-box 17 (SOX17), MYC ProtoOncogene (MYC), and Cyclin D1 (CCND1) were up-regulated (labeled in red), and gene expression of WNT Inhibitory Factor 1 (WIF1), Guanylate Binding Protein 3 (GBP3), Casein Kinase 1 Alpha 1 (CSNK1A1), Matrix Metallopeptidase 7 (MMP7) and Transcription Factor 7/ Lymphoid Enhancer Binding Factor 1 (TCF7/LEF1) were down-regulated (labeled in green). In planar cell polarity (PCP) signaling pathway, Wnt Family Member 11 (WNT11) was up-regulated and VANGL Planar Cell Polarity Protein 2 (VANGL2) was down-regulated. In Wnt/ Ca 2+ signaling pathway, Wnt Family Member 5 (WNT5) and Calcium/Calmodulin Dependent Protein Kinase II Alpha (CAMK2A) were up-regulated and Phospholipase C Beta 2 (PLCB2) was down-regulated. The expression levels of representative genes were further validated by qRT-PCR. Outcomes from qRT-PCR showed that consistent with the RNA-seq data, the mRNA levels of DKK2, SOX17, MYC, CCND1, CAMK2A, WNT11 and WNT5 were increased in facet joint osteoarthritis, while the mRNA levels of WIF1, CSNK1A1, TCF7/LEF1, and VANGL2 were decreased (Fig. 3B) .
Likewise, NF-κB signaling pathway was studied in detail. The schematic diagram of NF-κB signaling pathway obtained from KEGG Orthology online database showed that many genes involved in this signaling pathway were differentially expressed (Fig. 4A) . Notably, most of these differentially expressed genes were down-regulated, while C-C Motif Chemokine Ligand 4 and C-C Motif Chemokine Ligand 4 Like 2 (CCL4/CCL4L2) were up-regulated. The expression levels of representative genes in NF-κB signaling pathway were also determined by qRT-PCR. Outcomes from qRT-PCR were in accordance with RNA-seq outcomes that the mRNA levels of CCL4 and CCL4L2 were increased in facet joint osteoarthritis, while the mRNA level of BCL2 Related Protein A1 (BCL2A1) was decreased (Fig.  4B ).
Discussion
Facet joint osteoarthritis is a severe lumbar osteoarthritis disease and causes serious health issue. However, till now, the cellular and molecular bases of facet joint osteoarthritis have not been fully discovered. Therefore, in this study, by using RNA-seq, we explored the changes of mRNAs in facet joint osteoarthritis, aiming to facilitate a better understanding of molecular bases of facet joint osteoarthritis.
The application of RNA-seq allowed us to obtain a comprehensive recognition of genetic changes in facet joint osteoarthritis, including coding genes and non-coding genes. In this current study, we first focused on coding genes, determined the expression levels of these coding genes, and screened differentially expressed genes. Our study showed that among all identified coding genes, about 10% of genes were differentially expressed in facet joint osteoarthritis, and a large proportion of these differentially expressed genes were down-regulated in facet joint osteoarthritis.
Moreover, by using KEGG pathway analysis, we classified these differentially expressed genes to significant signaling pathways and screened numerous enriched signaling pathways. By a rough functional classification, we grouped top 30 enriched signaling pathways into four classes: disease-related signaling pathways, development-related signaling pathways, immune and inflammation-related signaling pathways, and cell growth and survival-related signaling pathways. Osteoarthritis has been recognized as an inflammatory disease since inflammation is implicated in the osteoarthritis pain process and cartilage degradation process (Berenbaum 2013; Rahmati et al. 2016) . Many inflammatory cytokines and inflammatory mediators, such as interleukin-1, interleukin-6, and tumor necrosis factor, were involved in the pathophysiology of osteoarthritis (Fernandes et al. 2002; Akeson and Malemud 2017; Suyasa et al. 2017) . Anti-inflammatory proteins were also demonstrated to exhibit a favorable role in the treatment of osteoarthritis (van Drumpt et al. 2016; Hix et al. 2017; Kon et al. 2018) .
Our study showed that among top 30 significantly enriched signaling pathway, a total of 11 enriched signaling pathways were related with immune and inflammation, including B cell receptor signaling pathway, primary immunodeficiency, Fc gamma R-mediated phagocytosis, natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Wnt signaling pathway, NF-κB signaling pathway, leukocyte transendothelial migration, Fc epsilon RI signaling pathway, NOD-like receptor signaling pathway, and phagosome. This, from the aspect of enriched signaling pathway, indicated the critical role of immune and inflammation in facet joint osteoarthritis.
Wnt signaling pathway and NF-κB signaling pathway have been identified to be involved in the development and progression of osteoarthritis (Corr 2011; Wu et al. 2012; Zhou et al. 2017) . Many molecules targeting and inhibiting Wnt signaling pathway have even been used to treat osteoarthritis (Blom et al. 2010; Takamatsu et al. 2014 ). In the current study, by using RNA-seq, we detected the changes of genes in the Wnt signaling pathway and NF-κB signaling pathway in facet joint osteoarthritis for the first time. The expression patterns of these differentially expressed genes were further validated by qRT-PCR. Moreover, it has been demonstrated that NF-κB signaling pathway is cross-linked with Wnt signaling pathway during inflammation (Ma et al. 2015; Ma and Hottiger 2016) . These observations indicated that Wnt signaling pathway and NF-κB signaling pathway might strongly participate in the process of facet joint osteoarthritis. Subsequent analysis will be performed to identify the functional roles of these differentially expressed genes in Wnt signaling pathway and NF-κB signaling pathway. Other identified top enriched signaling pathways will also be studied in the future.
Taken together, the current study, as far as we know, was the first RNA-seq transcriptome study of facet joint osteoarthritis. Our study might help to discover a set of differentially expressed genes in facet joint osteoarthritis, reveal significantly enriched signaling pathways, and thus contribute to the understanding of the molecular basis underlying facet joint osteoarthritis.
